Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) Sees Large Growth in Short Interest

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) was the target of a large growth in short interest in October. As of October 31st, there was short interest totalling 2,100 shares, a growth of 40.0% from the October 15th total of 1,500 shares. Based on an average trading volume of 16,400 shares, the days-to-cover ratio is presently 0.1 days.

Reviva Pharmaceuticals Price Performance

Shares of RVPHW traded up $0.03 during mid-day trading on Friday, hitting $0.19. 1,888 shares of the company’s stock were exchanged, compared to its average volume of 16,501. Reviva Pharmaceuticals has a 52 week low of $0.07 and a 52 week high of $1.62. The company has a 50-day simple moving average of $0.13 and a 200 day simple moving average of $0.20.

Reviva Pharmaceuticals Company Profile

Reviva Pharmaceuticals Holdings, Inc, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is brilaroxazine (RP5063), which is in Phase III clinical trials for use in the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attentiondeficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis.